Immunic
IMUX
IMUX
62 hedge funds and large institutions have $95M invested in Immunic in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.01% more ownership
Funds ownership: 0.07% → 0.08% (+0.01%)
77% less call options, than puts
Call options by funds: $754K | Put options by funds: $3.29M
Holders
62
Holding in Top 10
1
Calls
$754K
Puts
$3.29M
Top Buyers
| 1 | +$7.44M | |
| 2 | +$6.33M | |
| 3 | +$1.93M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.47M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$917K |
Top Sellers
| 1 | -$6.7M | |
| 2 | -$2.33M | |
| 3 | -$1.12M | |
| 4 |
Goldman Sachs
New York
|
-$936K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$416K |